Studying the trend and progress on Covid -19 pandemic from 29th January to 4th of February 2022 across different countries of the world.
- March 15, 2022
- Posted by: rsispostadmin
- Categories: COVID-19, IJRISS, Public Health, Social Science
International Journal of Research and Innovation in Social Science (IJRISS) | Volume VI, Issue II, February 2022 | ISSN 2454–6186
Joseph Oyepata Simeon1, Joseph Opeyemi Tosin2, Sabastine Aliyu Zubairu3, Joseph Sunday Oyepata4
1Departmennt of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Federal University, Oye–Ekiti, Ekiti State, Nigeria.
2Department of Pharmacy, University College Hospital, Ibadan, Oyo State, Nigeria
3Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Gombe State University, Gombe State, Nigeri.
4Mechanical Engineering Department, Faculty of Engineering, Ambrose Alli University, Ekpoma, Edo State, Nigeria.
Author to whom correspondence should be addressed
Joseph Oyepata Simeon
ABSTRACT
Background and Objective: According to WHO most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment.Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment.. This work is aim at Studying the trend and progress on Covid -19 pandemic from 29th January to 4th of February 2022 across different countries of the world.
Material and Method:Data from one hundred and seventy two (172)countries and regions of the world weregotten from United Nations Geoscheme. Results were collated and subsequently compared to the values obtained for USA.
Result:Europe and America still have high situation rate of the virus.Compared to the USA most European countries tend to have lower mortality factor when compared to incidence factor. Asia also has a relatively high incidence and mortality factor, while Africa has little to no comparism factor value. The Omicron is the most predominant strain with high infectivity rate as the original virus.
Conclusion:despite various variant of COVID-19, Africa appears to developed a natural surval mechanism. There is therefore need for the rest of the globe to further investigate the reason for this spared onslaught and develop vaccine based on AfricansCOVID-19 antibody make up so as to develop a more robost immunity
Keyword: Africa, USA, COVID-19, America, Nigeria, Europe, continent
INTRODUCTION
Coronaviruses are a family of viruses that can cause respiratory illness in humans (1,2). They are called “corona” because of crown-like spikes on the surface of the virus (3). Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and the common cold are examples of coronaviruses that cause illness in humans (4,5,6).The new strain of coronavirus — COVID-19 — was first reported in Wuhan, China in December 2019 (7). The virus has since spread to all continents. Coronaviruses are often found in bats, cats and camels (8,9). The viruses live in but do not infect the animals. Sometimes these viruses then spread to different animal species. The viruses may change (mutate) as they transfer to other species. Eventually, the virus can jump from animal species and begins to infect humans (11). In the case of COVID-19, the first people infected in Wuhan, China are thought to have contracted the virus at a food market that sold meat, fish and live animals (12). Although researchers don’t know exactly how people were infected, they already have evidence that the virus can be spread directly from person to person through close contact. The Omicron variant (B.1.1.529) is a variant of SARS-CoV-2 (the virus that causes COVID-19) that was first reported to the World Health Organization (WHO) from South Africa on 24 November 2021 (13). Omicron multiplies around 70 times faster than the Delta variant in the bronchi (lung airways) but evidence suggests it is less severe than previous strains, especially compared to the Delta variant. Omicron might be less able to penetrate deep lung tissue (14).
There is serious concern and study on the different waves of the disease has. This have been suggested to be due to change in weather and continuously mutated strain of the virus that has been identified (11, 12,14). There is the need to study this cases per country and region with respect to the virulent and spreadability of the mutated strain. Also, some interesting studies has been carried out on the dermographic, nature and strength of the virus, but analyzing an updated information per time is also predicated in managing the trend(16,17). The aim of this study is to provide update report on progress on Covid -19 pandemic from 19th-25th January, 2022 across different countries of the world.